Author:
Pietrantonio Filippo,Biondani Pamela,Ciurlia Elisa,Fanetti Giuseppe,Tessari Anna,Bertarelli Gaia,Bossi Ilaria,Musella Valeria,Melotti Flavia,Di Bartolomeo Maria,Valvo Francesca,Pellegrinelli Alessandro,Milione Massimo,Perrone Federica,de Braud Filippo
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference60 articles.
1. Miyashita T, Reed JC. Tumor suppressor TP53 is a direct transcriptional activator of the human BAX gene. Cell. 1995;80(2):293–9.
2. Raffo AJ, Kim AL, Fine RL. Formation of nuclear BAX/TP53 complexes is associated with chemotherapy induced apoptosis. Oncogene. 2000;19(54):6216–28.
3. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, et al. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995;55:4471–8.
4. Kupryjańczyk J, Szymańska T, Madry R, Timorek A, Stelmachów J, Karpińska G, et al. Evaluation of clinical significance of TTP53, BCL2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. Br J Cancer. 2003;88(6):848–54.
5. Gascoyne RD, Krajewska M, Krajewski S, Connors JM, Reed JC. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin’s lymphoma. Blood. 1997;90(8):3173–8.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献